Effect of Oral D-mannose Tablets on Pharmacokinetics of Dabigatranate in Healthy Adults

NARecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

December 31, 2024

Conditions
Health
Interventions
DRUG

Dabigatran Etexilate

Subjects will receive a single oral dose of 110mg (low dose specification in the instructions) or lower of dabigatran etexilate on an empty stomach on the morning of day 1 and day 16 of the trial period.

DIETARY_SUPPLEMENT

D-mannose

Subjects will take 3g (1g\*3 tablets) of D-mannose tablets every morning and evening from the 2nd day to the 15th day of the trial period, with a total of 6g/day (medium dose specification in the instructions).

Trial Locations (1)

100191

RECRUITING

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER